GERD (acid reflux) decisions — 2025

The appeal was withdrawn by the Veteran in January 2025, and all issues have been dismissed.

The Board dismissed the Veteran's appeals for service connection for a back disability, right shoulder, and GERD due to untimely Notice of Disagreement.

The Board granted service connection for gastroesophageal reflux disease (GERD) as secondary to the Veteran's service-connected disability, resolving all doubt in favor of the Veteran.

The Board granted service connection for obstructive sleep apnea and migraine headaches, both secondary to the Veteran's service-connected posttraumatic stress disorder (PTSD) and chronic sinusitis. The claims for diabetes mellitus type II, hypertension, and gastroesophageal reflux disease were remanded for further development.

The Board granted the Veteran's notice of disagreement and service connection for tinnitus, while remanding claims for headaches, GERD, and a respiratory condition due to potential exposure during Gulf War service.

The Board remands the claims for increased disability ratings for left knee scar and GERD due to pre-decisional duty-to-assist errors.

The Board denied the Veteran's claims for increased ratings for paroxysmal sinus tachycardia, esophagus stricture of with eosinophilic and herpetic esophagitis, and gastroesophageal reflux disease (GERD).

The veteran and his representative requested the withdrawal of the appeal, and the Board has dismissed all issues.

The Board remands the claims for an increased rating of PTSD and service connection for OSA and gastroesophageal disability to obtain a medical opinion in compliance with the PACT Act.

The Board remands the issues of entitlement to service connection for a left knee disability, a rating in excess of 10 percent for gastroesophageal reflux disease (GERD), and a compensable rating for a right knee disability for further development.

The Board denied service connection for a bilateral eye disability manifested by blurry vision and remanded the claims for service connection for psoriasis, arthritis of the back, right and left knee disabilities, and a gastrointestinal disability.

The Board granted service connection for erectile dysfunction and remanded claims for fibromyalgia, irritable bowel syndrome (IBS), migraine headaches, and obstructive sleep apnea due to inadequate VA examinations.

The appeal for a higher rating for migraine headaches with nausea was denied, and the appeal for service connection for residuals of right inguinal hernia was dismissed. Several other claims were remanded for further development.

The Board granted a 30 percent disability rating for GERD, but denied service connection for right knee pain, shortness of breath, and sleep apnea.

The Board denied service connection for diabetes mellitus type 2, ischemic stroke, gastrointestinal reflux disease (GERD), and atrophoderma disorder as the evidence did not support a finding that these conditions were incurred in or caused by active military service. A psychiatric disorder was remanded for further development.

The Board remands the claims for service connection for gastroesophageal reflux disease and sleep apnea as they require further development, specifically new VA opinions regarding whether these conditions are aggravated by the Veteran's service-connected PTSD.

The Board remands the claims for service connection and an increased rating due to deficiencies in VA's duty to assist.

The Board granted service connection for persistent depressive disorder and somatic symptom disorder, and assigned a 70 percent rating for other specified trauma and stressor related disorder with mild alcohol use disorder. The claims for increased ratings for the right shoulder strain and IBS were denied.

The Board granted service connection for obstructive sleep apnea and GERD as secondary to a service-connected disability, but denied service connection for arthritis and polyneuropathy.

The Board denied service connection for gastroesophageal reflux disease (GERD) as secondary to irritable bowel syndrome and an initial rating greater than 10 percent for irritable bowel syndrome.